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ABSTRACT
The p53 protein is crucial for adapting programs
of gene expression in response to stress. Recently,
we revealed that this occurs partly through the for-
mation of stress-specific p53 binding patterns.
However, the mechanisms that generate these
binding patterns remain largely unknown. It is not
established whether the selective binding of p53
is achieved through modulation of its binding
affinity to certain response elements (REs) or via a
chromatin-dependent mechanism. To shed light on
this issue, we used a microsphere assay for protein–
DNA binding to measure p53 binding patterns on
naked DNA. In parallel, we measured p53 binding
patterns within chromatin using chromatin immuno-
precipitation and DNase I coupled to ligation-
mediated polymerase chain reaction footprinting.
Through this experimental approach, we revealed
that UVB and Nutlin-3 doses, which lead to different
cellular outcomes, induce similar p53 binding
patterns on naked DNA. Conversely, the same treat-
ments lead to stress-specific p53 binding patterns
on chromatin. We show further that altering chro-
matin remodeling using an histone acetyltransferase
inhibitor reduces p53 binding to REs. Altogether,
our results reveal that the formation of p53 binding
patterns is not due to the modulation of sequence-
specific p53 binding affinity. Rather, we propose
that chromatin and chromatin remodeling are
required in this process.
INTRODUCTION
p53 controls cell fate in response to stress and is
one of the ﬁrst barriers against the process of carcino-
genesis. In response to stress, p53 binds to its response
elements (REs), which follow the pattern 50-RRR
CWWGYYYnRRRCWWGYYY-30 (R=purine; Y=
pyrimidine; W=adenine or thymine), and then regulates
the transcription of genes involved in major cellular
pathways (1–3). Depending on the stress context,
p53 induces reversible cell cycle arrest, senescence, or
apoptosis (4).
How p53 triggers stress-speciﬁc responses is an unre-
solved question (5). One hypothesis proposes that in
response to a given stress, p53 binds only to the REs
located near or within genes that need to be regulated,
leading to stress-speciﬁc p53 binding patterns (see refer-
ence 6 for a review on mechanisms of transcription factor
selectivity). Until now, this model remained challenged by
the observation that, independent of the type of stress, p53
binds to most of its REs in cell lines (7,8). However, a
recent report revealed that the absence of stress-speciﬁc
p53 binding patterns might be a feature of cell lines
(9,10). Moreover, using p21 and its ﬁve p53 REs as a
model gene, we showed that stress-speciﬁc p53 binding
patterns actually occur in human primary cells and correl-
ate with speciﬁc p21-variant transcription proﬁles (11).
The fact that 15% of validated p53 effector genes
contain multiple p53 REs suggests that this type of regu-
lation might occur at multiple other genomic loci (3).
Altogether, these observations emphasize the fact that
p53 binding patterns are an important mechanism for
the regulation of p53 effector genes and the adaptive
response to stress.
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stress-speciﬁc p53 binding patterns. Evidence suggests
that posttranslational modiﬁcations and/or targeting co-
factors favor p53 binding to speciﬁc REs. For example,
UV-induced Ser46 phosphorylation directs p53 to the
promoter of pro-apoptotic genes (12), and Lys320 acetyl-
ation favors p53 binding to cell-cycle-arrest gene pro-
moters (13). Moreover, targeting co-factors ASPP1,
ASPP2 and BRN3B favor p53 binding to pro-apoptotic
genes while iASPP, Hzf and BRN3A have the opposite
effect (14–19). However, how these selective bindings
are achieved remains largely unknown. Importantly, it is
not known whether stress-induced p53 binding patterns
are caused by the modulation of p530s binding afﬁnity
to RE sequences or through a chromatin-dependent
mechanism.
To shed light on this issue, we exposed human normal
primary and human Li-Fraumeni ﬁbroblasts to different
doses of UVB or Nutlin-3 in order to generate different
p53 binding patterns and distinct cellular outcomes. We
then measured p53 binding activity on naked DNA with a
microsphere assay for protein–DNA binding (MAPD)
(20). This multiplexed test uses nuclear extracts to
quantify p53 binding to oligonucleotides containing
REs. Thus, while the nuclear protein context is preserved,
MAPD overcomes the effect of chromatin to assessing
whether p53 binding afﬁnity to speciﬁc RE sequences
is modulated in a stress-dependent manner. In parallel,
we also measured p53 binding patterns in cells on
chromatinized DNA. We used chromatin immuno-
precipitation (ChIP), which reveals the presence of a
protein within a given region of genomic DNA, as well
as DNase I digestion coupled to ligation-mediated poly-
merase chain reaction (PCR) footprinting (DLF), which
maps protein–DNA interactions at single-nucleotide
resolution and establishes the occupancy status of a
RE. The combination of these techniques allowed us to
investigate the inﬂuence of chromatin on the formation
of p53 binding patterns. Finally, remodeling of chromatin
by acetylation of nucleosomal histones is an important
mechanism that regulates gene expression (21). Using
the histone acetyltransferase inhibitor (HATi) Garcinol,
which inhibits the histone acetyltransferases (HAT)
p300 and pCAF, we investigated whether chromatin
remodeling is involved in the regulation of p53 binding
to REs (22).
In this article, we show that stress-speciﬁc p53 binding
patterns are not caused by modulation of p53 binding
afﬁnity to speciﬁc REs. Rather, chromatin and chromatin
remodeling appear to make signiﬁcant contributions to
the regulation of p53 binding activity and the formation
of p53 binding patterns.
MATERIALS AND METHODS
Cells and cell culture
Human normal primary skin ﬁbroblasts (considered wild-
type ﬁbroblasts or wt) and human Li-Fraumeni (LF) skin
ﬁbroblasts (LF041 strain, a gift from M. Tainsky,
University of Texas M. D. Anderson Cancer Center,
Houston, TX, USA) were grown in Dulbecco’s Modiﬁed
Eagle Medium (DMEM) containing 10% FBS, 0.2U/mL
penicillin G and 100mg/mL streptomycin, all from Wisent
Bioproducts (St. Bruno, QC, Canada). LF041 ﬁbroblasts
have lost one p53 allele and carry a frameshift mutation at
codon 184 in the remaining copy.
Cell treatments
UVB irradiations of 250, 500 and 2000J/m
2 were per-
formed with FS20T12/UVB/BP tubes (Philips, Franklin
Square Drive, NJ, USA); wavelengths below 290nm
were ﬁltered by a clear 0.015-inch Kodacel TA-407
(Eastman Kodak, Rochester, NY, USA). The dose was
measured using a UVX Digital Radiometer (UVP Inc.,
Upland, CA, USA). Induction of p53 in the absence of
stress was carried out using 1, 2.5 and 10mM of Nutlin-3
(Sigma, St. Louis, MO, USA). For the inhibition of
histone acetyltransferase (HAT), cells were treated with
10, 25 and 50mM of Garcinol (Sigma, St. Louis, MO,
USA) for 2h, then irradiated with UVB and reincubated
for 12h in the presence of Garcinol.
Cell-cycle analysis
DNA was stained using DAPI as previously described
(23). DAPI ﬂuorescent signal was quantiﬁed by laser
scanning cytometry (LSC) using the iCys Research
Imaging Cytometer (Compucyte, Cambridge, MA, USA)
(11). A minimum of 1500 cells per experimental condition




4 cells were seeded 24h prior to UVB or Nutlin-3
treatments. For UVB, cells were counted 2 and 6 days
after irradiation. For Nutlin-3, cells were treated for 24h
and then grown in Nutlin-3 free medium until counting on
Days 2 and 6. Experiments were performed in triplicate.
Measurement of apoptotic cells
Fibroblasts were plated 24h prior to UVB irradiation or
incubation with Nutlin-3 for 24h. Cells were then har-
vested 48h post-treatment and cells were stained using
the Vybrant 3 apoptosis kit (Molecular Probes, Eugene,
OR, USA). Apoptotic cells were then quantiﬁed using a
FACScan (Becton Dickinson, San Jose, CA, USA).
p21 mRNA quantiﬁcation
The measurement of p21 mRNA was performed by qPCR
as previously described (11).
Microsphere assay for protein–DNA binding
Oligonucleotides for MAPD (Invitrogen, Carlsbad, CA,
USA) consisted of a forward oligonucleotide composed
of 50 ‘anti-tag’ sequences followed by p53 REs ﬂanked
with 45nt of their respective genomic sequences (Table
S1). The forward oligonucleotide was hybridized to a
unique ‘tag’ sequence on each MicroPlexTM-xTAG
microsphere (Luminex, Austin, TX, USA). The reverse
oligonucleotide was complementary to the forward
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nucleotides and MicroPlexTM-xTAG microspheres were
hybridized as previously described (20).
To evaluate p53 binding patterns, nuclear extracts
were prepared using the nuclear-extract kit from Active
Motif (Carlsbad, CA, USA) and p53 binding was
measured using the MAPD assay as previously described
(20,24). A non-binding sequence (negative control WRNC)
and a positive binding sequence [positive control ConC
GGGCAA GTCTGGGCAAGTCT, which is a perfect
match with the p53 consensus RE (25,26)] were examined
in each reaction, untreated cells served as a negative
control. Microspheres were multiplexed and added to p53
binding buffer supplemented with a non-competing
double-stranded oligonucleotide (TransAm p53 kit,
Active Motif, Carlsbad, CA, USA). Beads were incubated
for 1h in the presence of 5mg of nuclear extracts.
Microspheres were then incubated for 30min with
primary antibodies against p53 followed by a 30-min
incubation with phycoerythrin-conjugated secondary
antibodies. Fluorescence intensity was measured by ﬂow
cytometric analysis using a Bio-Plex 200 System
(Bio-Rad, Hercules, CA, USA). p53 binding ﬂuorescence
was normalized as previously described (20).
Immunoblotting
The blots were probed with primary antibodies (Santa
Cruz Biotechnology, Inc., Santa Cruz, CA, USA) for
p53 (DO-1) and actin (C-11). Bands were detected using
horseradish peroxide-conjugated secondary antibodies
(Santa Cruz) and the ECL Western Blotting System
(Amersham Biosciences, Piscataway, NJ, USA).
Chromatin immunoprecipitation
ChIP assays were performed as previously described (27).
Samples were sonicated to generate 500-bp DNA frag-
ments. Immunoprecipitations were carried out using
anti-p53 antibody DO-1 from Santa Cruz Biotechnology
(Santa Cruz, CA, USA), anti-H3 antibody from Abcam
(Cambridge, MA, USA), and anti-acetyl-H3 and anti-
acetyl-H4 antibodies from Millipore (Billerica, MA,
USA). Preimmune and no antibody controls were also per-
formed. qPCR was done using the primer sets speciﬁc for
the p53 REs located on p21 (Table S2). ChIP experiments
were performed in duplicate.
DNase I coupled to ligation-mediated PCR footprinting
DNase I footprinting reaction was carried out as previ-
ously published (11,28). The p53 REs located on p21 were
studied using the primer sets reported in Table S3. We
used ImageQuant 5.0 (Molecular Dynamics, Sunnyvale,
CA, USA) to quantify sequencer TIF ﬁles (Figure S1)
and determine gel-band-intensity proﬁles. Data were ﬁrst
corrected for the gel background ﬂuorescence. For each
lane, we then calculated the average band-intensity outside
of the footprint area (ABIout). The ABIout was then used
to normalize intensity between non-treated and treated
lanes. The ratio between ABIout of non-treated lanes
and treated lanes to be corrected was computed and
used to normalize the intensity of treated lanes to that
of the non-treated lane. Bands were identiﬁed by the
presence of a local intensity maximum. Band-intensity
was calculated by adding the intensity values of the
5 pixels centered on the local intensity maximum of
the band. Band-intensity ratios between treated and
non-treated samples were then computed, also as the
5-band-interval mobile averages (Figure S2). Negative-
footprint-intensity averages were calculated by averaging
the mobile-average values encompassed in the RE
sequence.
RESULTS
Choice of treatments and doses
In order to induce unique p53 binding patterns, we
exposed human primary ﬁbroblasts to distinct treatments
and treatment doses. We used 250, 500 and 2000J/m
2
UVB to induce p53 accumulation following genotoxic
stress. As a control, we used 1, 2.5 and 10mM Nutlin-3
to induce p53 accumulation in the absence of stress
context through the inhibition of p53-MDM2 inter-
actions. Interestingly, UVB leads to a plethora of
well-characterized p53 posttranslational modiﬁcations
(29), while Nutlin-3 induces few modiﬁcations of p53
(30,31). Thus if p53 afﬁnity to REs is modulated in a
stress-speciﬁc context (e.g. posttranslational modiﬁcations
or co-factors) and stress intensity, one would expect that
these treatment conditions will generate distinct p53
binding patterns.
UVB and Nutlin-3 treatments lead to different cellular
outcomes
We ﬁrst veriﬁed the effect of treatment doses on cellular
outcomes. Wild-type (wt) and LF ﬁbroblasts were treated
with UVB and Nutlin-3 doses and cell cycle, cell prolifer-
ation and apoptosis were monitored (Figure 1).
UVB doses induced different cell-cycle-arrest responses.
In wt ﬁbroblasts, a G1/S arrest was observed following
250J/m
2 while 500J/m
2 arrested cells in G2/M and
2000J/m
2 did not affect the cell cycle (Figure 1A). In LF
ﬁbroblasts, both 250J/m
2 and 500J/m
2 doses induced a
G2/M arrest while 2000J/m
2 had no effect on cell-cycle
progression. The UVB doses also affected cell prolifer-
ation differently. In wt ﬁbroblasts, cell growth was
reduced following 250J/m
2, arrested by 500J/m
2, and
apoptosis was induced at 2000J/m
2 (Figure 1B and C).
The absence of p53 in LF ﬁbroblasts sensitized the cells
to UVB. The 250J/m
2 dose strongly reduced cell growth
while 500 and 2000J/m
2 induced apoptosis (Figure 1B
and C).
The cell response to Nutlin-3 led to a decrease in
S phase cells through a G1/S arrest in wt ﬁbroblasts
only (Figure 1A). Cell proliferation was reduced as
Nutlin-3 concentration increased but the highest dose
was not sufﬁcient to stop cell growth entirely and no apop-
tosis was observed (Figure 1B and C).
Thus, 250, 500 and 2000J/m
2 UVB induced transient
cell-cycle arrest, permanent cell-cycle arrest and apoptosis,
respectively, while 1, 2.5 and 10mM Nutlin-3 only induced
cell-cycle arrests.
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and Nutlin-3 treatments
In order to study p53 binding patterns on different REs,
we used p21 and the ﬁve p53 REs located at +3253,
 1354,  2242,  3969 and  11708bp from its transcrip-
tion start site as a model gene (Figure 1D) (7,32–34). We
followed p21 mRNA levels to determine the best time
conditions to measure p53 transcriptional binding
activities and to investigate whether the different cellular
outcomes were correlated with speciﬁc p21 transcription
proﬁles.
UVB treatment doses induced three distinct p21 mRNA
transcription proﬁles that correlated with the three differ-
ent cellular outcomes (Figure 1E). p21 mRNA induction
was lower and shorter in wt ﬁbroblasts than in LF ﬁbro-
blasts following 250J/m
2, indicating that the presence of
p53 repressed p21 transcription. The 500J/m
2 dose led to
p53-dependent induction of p21 mRNA only after 8h in
wt ﬁbroblasts when compared with LF ﬁbroblasts. No
augmentation of p21 mRNA level was observed following
2000J/m
2 in wt or LF ﬁbroblasts. Finally, Nutlin-3
exposure increased p21 mRNA levels in a dose-dependent
manner only in wt ﬁbroblasts (Figure 1E). Based on these
transcription proﬁles, we decided to study p53 transcrip-
tional activities at 2, 6 and 12h.
UVB and Nutlin-3 treatment doses lead to similar p53
binding patterns on naked DNA
We wondered whether the formation of p53 binding
patterns is caused by a stress-dependent regulation of
p53 binding afﬁnity to speciﬁc RE sequences. To answer
this question, we measured p53 binding activity to the ﬁve
REs of p21 in a naked DNA context using the MAPD
assay and nuclear extracts of ﬁbroblasts treated with
Nutlin-3 or UVB doses (20). We observed the most
intense binding with 500J/m
2 UVB and 10mM Nutlin-3
(Figures 2A and S3). For each Nutlin-3 dose, p53 binding
increased in a time-dependent manner and was maximal at
Figure 1. UVB and Nutlin-3 treatment doses induce different cellular outcomes and transcription of p21.( A) Measurement of cell cycle. wt and LF
ﬁbroblasts were exposed to UVB and Nutlin-3 and the percentage of cells in each phase was determined 24-h post-treatment. (B) Measurement of cell
proliferation. wt and LF ﬁbroblasts were exposed to UVB and Nutlin-3 and cells were counted at Day 2 and Day 6. (C) Measurement of apoptotic
cells. wt and LF ﬁbroblasts were exposed to UVB and Nutlin-3 and apoptotic cells were measured 48h post-treatment. (D) Sequences of the different
p53 RE located on the p21 gene, arrows indicate RE pentamers orientations. (E) Measurement of p21 mRNA induction kinetic. wt ﬁbroblasts and
LF ﬁbroblasts were exposed to UVB and Nutlin-3 and mRNA were analyzed by means of qPCR. Arrows indicate the induction times retained to
measure p53 transcriptional binding activities. Note: All experiments were performed in triplicate and data are presented as mean ± SD.
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at 6h and decreased at 12h for all REs (Figures 2A
and S3). Since p53 protein level remained high at 12h
following UVB (Figure S4), which suggests that p53
binding activity was globally inhibited at this time, after
6h, UVB and Nutlin-3 induced similar binding intensities
between REs. The  1354 and  2242bp REs were highly
bound by p53 similar to the positive control ConC, while
the  3969 and  11708bp REs displayed less pronounced
levels of p53 binding (Figure 2A). Strikingly, no p53
binding to the +3253bp RE was observed. Using
DLF, we previously reported that we were not able to
measure p53 binding to this RE in cells (11). Thus, this
sequence may not be a bona ﬁde p53 RE or is a very low
afﬁnity RE.
Subsequently, we investigated the effect of treatment
doses on p53 binding patterns. We used scatter plot rep-
resentation of data to compare the binding patterns
obtained following UVB and Nutlin-3 doses. If binding
patterns are similar, the RE binding intensities from two
different conditions result in a correlation factor (R
2) close
to 1. As seen in Figure 2B, the p53 binding patterns
obtained were similar for the different UVB doses tested
despite the different cellular outcomes they generated
(R
2 values ranged from 0.89 to 0.98). Only the global
binding activity to all REs varied among UVB conditions,
which is reﬂected by regression-line slopes (m) different
from 1 and from each other (Figure 2B). Similar observa-
tions were made following Nutlin-3 treatments. p53
binding patterns were comparable between the different
Nutlin-3 doses since R
2 values ranged from 0.83 to 0.99
(Figure 2B).
We then asked whether UVB- and Nutlin-3-induced p53
binding patterns were different. We compared the p53
binding obtained for the different UVB doses with the
10mM Nutlin-3 dose (Figure 2C). The UVB doses
yielded similar p53 binding patterns to 10mM Nutlin-3
(R
2 values ranging from 0.77 to 0.95). The same observa-
tions were made when we compared the UVB doses with 1
or 2.5mM Nutlin-3 (Figure S5).
Finally, we wondered whether these observations were
valid for REs located near other genes. Using MAPD, we
measured p53 binding activities on the  83bp and
+354bp REs of Bax and the +762bp and +724bp REs
of MDM2 (Figure S6). We obtained R
2 values close to 1,
indicating that these REs were also bound similarly fol-
lowing exposure to Nutlin-3 and UVB doses. Altogether,
these data led to the conclusion that different treatment
doses, which lead to different cellular outcomes, induce
similar p53 binding patterns on naked DNA. This
suggests that p53 binding afﬁnity to speciﬁc RE sequences
is not a function of the type of stress experienced by
the cell.
UVB and Nutlin-3 treatments induce stress-speciﬁc p53
binding patterns in cells on chromatinized DNA
Since no p53 binding patterns were observed on naked
DNA, we then investigated whether stress-speciﬁc p53
binding patterns are scored within chromatin. To this
end, we used ChIP and DLF to measure p53 binding
patterns on the REs located in p21 in ﬁbroblasts following
exposure to 500J/m
2 UVB and 10mM Nutlin-3 (Figure 3).
We selected these treatment doses because they induced
high and comparable p53 binding intensities on naked
DNA (m=0.94, Figure 2C).
Initially, measurement of p53 binding activity by ChIP
revealed that Nutlin-3 and UVB treatments led to similar
p53 binding patterns within chromatin (Figure 3).
However, these data differed to what we observed on
naked DNA by several key points. For example, p53
was located at the  1354,  2242 and  11708bp REs,
but was never found associated to the  3969bp RE
although p53 bound this RE on naked DNA
(Figures 2A and 3). Moreover, in contrast to the results
obtained with the  2242bp RE, p53 binding to the
 1354bp RE was less intense on chromatin than on
naked DNA (Figures 2A and 3). Finally, while p53
binding activities were strongly reduced at 12h following
UVB, as measured by MAPD (Figure 2A), ChIP revealed
substantial p53 binding to REs at this time in cells.
Since no stress-speciﬁc p53 binding patterns were
observed using ChIP, we used DLF to precisely investigate
the occupancy status of p53 REs (35). We did not observe
any footprints in LF ﬁbroblasts (data not shown) (11). In
wt ﬁbroblasts, footprints were identiﬁed for the  1354,
 2242 and  11708bp REs but not the  3969bp RE,
which conﬁrmed the ChIP results (Figure 3). However,
following Nutlin-3 treatments, p53 was detected at the
 11708bp RE by ChIP, but no occupancy of this RE
was measured by DLF. Although DLF is less sensitive
than ChIP (footprints are rarely observed below 0.1% of
ChIP input), we ruled out any sensitivity issue regarding
this result since DLF was capable of measuring p53
binding to the  11708bp RE following UVB. Thus, con-
versely to experiments performed on naked DNA,
stress-speciﬁc p53 binding patterns were observed on
chromatinized DNA using DLF. Altogether, these data
indicate that chromatin affects p530s interaction with
REs and is important for the formation of p53 binding
patterns.
UVB doses modulate p53 binding to the  2242bp RE,
and accessibility to this RE is affected by HATi Garcinol
We next decided to investigate how p53 binding patterns
are modulated in cells following different UVB doses that
induce distinct cellular outcomes. Using DLF, we
compared p53 binding activities following 500 and
2000J/m
2 UVB, which induce cell-cycle arrest and apop-
tosis, respectively. We observed that the  2242bp RE was
the only RE bound differently following these treatments
(Figure 4A). As reported above, no speciﬁc modulation of
p53 binding afﬁnity was observed on naked DNA follow-
ing 500 and 2000J/m
2 UVB for this RE (Figure 2B). Since
we observed that chromatin is important for the forma-
tion of p53 binding patterns, we investigated if chromatin
remodeling, such as histone acetylation, could modulate
p530s interaction with REs. To this end, we used HATi
Garcinol, which is a well-characterized inhibitor of histone
acetyltransferases p300 and pCAF (22). wt ﬁbroblasts
were pre-treated for 2h with 0–50mM of Garcinol,
Nucleic Acids Research,2011, Vol.39, No. 8 3057Figure 2. UVB and Nutlin-3 treatment doses lead to similar p53 binding patterns on naked DNA. (A) In vitro measurement of p53 binding activities
using MAPD. wt ﬁbroblasts were exposed to 500J/m
2 UVB or to 10mM Nutlin-3 then collected at 2, 6 and 12h for nuclear extract preparation. p53
binding to the REs located on p21 and to the positive control sequence (ConC) was measured by MAPD. Binding measured on the negative control
sequence (WRNC) was subtracted from values obtained for the other REs. Experiments were performed in triplicate and data are presented as mean
± SD. (B) Permutative comparisons of binding intensities measured by MAPD on the p53 REs located on p21 following UVB and Nutlin-3
treatment. Each data set obtained at 6h for a treatment dose was compared with the other doses using scatter plot representation. (C) Permutative
comparisons between p53 binding intensities obtained following 250, 500 and 2000J/m
2 UVB and 10mM Nutlin-3. Each data set obtained at 6h for
the three UVB doses was compared with the data set obtained at 6h with 10mM Nutlin-3. Nomenclature: open rectangle, WRNC; G, ConC; open
rhombus, +3253bp RE; open circle, –1354bp RE; plus symbol, –2242bp RE; Times symbol, –3969bp RE; open triangle, –11708bp RE.
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2 UVB, and then reincubated for 12h
in the presence of Garcinol before being collected. We
ﬁrst measured if Garcinol treatment affected p53 levels.
We observed that this was not the case (Figure 4B). As
p53 is a target of HAT and since acetylation of p53
might affect its interaction with REs, we used MAPD
to determine whether HATi Garcinol had an effect on
p53 binding activity on naked DNA. We observed that
inhibition of HAT increased p53 binding activity to all
REs on naked DNA as observed for the  2242bp RE
on Figure 4C. We then investigated the effect of HATi
Garcinol on p53 binding activity on chromatinized DNA
in cells. To this end, we monitored p53 binding to the
 2242bp RE in wt ﬁbroblasts using DLF (Figure 4D
and E). We observed that inhibition of HAT alone had
no effect on the occupancy of the  2242bp RE (Figure
4D compare lanes 5 and 6, Figure 4E). However, follow-
ing UVB treatment, the occupancy of the  2242bp RE
strongly decreased as Garcinol concentration increased
(Figure 4D and E); this was also conﬁrmed by ChIP
(Figure S7). Thus, in contrast to the results obtained
on naked DNA, inhibition of HAT decreases p53 inter-
action with the  2242bp RE in a chromatinized DNA
context. To assess whether chromatin remodeling was
affected by HATi Garcinol, we monitored histone H3
and H4 acetylation levels by ChIP (Figure 4F). At the
actively bound  2242bp RE, histones H3 and H4 were
acetylated in non-stressed cells and acetylation increased
following exposure to UVB. On the other hand, the
acetylation level of histones located at the  3969bp
RE remained very low even after UVB irradiation.
Interestingly, in the presence of HATi Garcinol a
decrease in histone acetylation was observed. We thus
concluded that p530s interaction with REs is correlated
with the acetylation level of histones.
DISCUSSION
How p53 achieves speciﬁc gene regulation in response to
stress is an unresolved and exciting question in the ﬁeld.
We and others recently showed that different stresses
trigger different p53 binding patterns in primary cells
(9,11). We demonstrated that p53 binds differently to
the multiple REs located on the p21 gene to regulate p21
variant transcriptions, revealing the crucial role of p53
binding patterns in the adaptive response to stress (11).
However, the mechanism that produces these binding
patterns remained largely unknown. Here, we showed
that the formation of p53 binding patterns is not caused
by a stress-dependent modulation of p53 binding afﬁnity
to RE sequences. Rather, we demonstrated that chromatin
is needed for the formation of p53 binding patterns
and that chromatin remodeling inﬂuences p53 interaction
with REs.
Several lines of evidence support the view that
posttranslational modiﬁcations of p53 and targeting
co-factors direct p53 to bind to certain REs in a stress-
dependent manner (12–19). The modulation of p53
binding afﬁnity to speciﬁc RE sequences is one mechanism
proposed to explain how posttranslational modiﬁcations
and targeting co-factors direct p53 binding to generate p53
binding patterns. The results reported in this article
suggest that this is not the case. The p53 binding
patterns observed on naked DNA remained virtually iden-
tical following UVB and Nutlin-3 treatments, known to
induce different p53 posttranslational modiﬁcations and
leading to different cellular outcomes. This observation
raises questions about how posttranslational modiﬁca-
tions and targeting co-factors direct p53 binding. Since
we only observed stress-speciﬁc p53 binding patterns
within chromatin, we propose that posttranslational
modiﬁcations and the targeting of co-factors most likely
requires the presence of chromatin to inﬂuence p53
binding to certain REs. In support of this view, crosstalk
between p53 modiﬁcations and histone H3 modiﬁcations
have been recently observed, suggesting that histones
might play a role in the regulation of p53 functions (36).
Nevertheless, it has also been shown that p53 acetylated
on Lys120 is speciﬁcally found at cell-cycle-arrest genes,
but this modiﬁcation is induced at a post-binding level
Figure 3. UVB and Nutlin-3 treatments induce stress-speciﬁc p53 binding patterns in cells on chromatin. wt and LF ﬁbroblasts were exposed to
UVB and Nutlin-3 then collected at 2, 6 and 12h. p53 binding to the REs located on p21 was then measured by ChIP (white) and DLF (black).
Nucleic Acids Research,2011, Vol.39, No. 8 3059(37,38). Thus, an important point that needs to be ad-
dressed, regarding the role of posttranslational modiﬁca-
tions in p53 targeting, is whether they effectively direct
p53 to speciﬁc REs or whether they are induced at
speciﬁc REs as a post-binding event.
One admitted view is that binding afﬁnity and protein
concentration are two crucial factors regulating protein
interactions with DNA. Indeed, if binding afﬁnity is
high, the protein will bind even if it is present at a lower
concentration. While on the other hand, if the binding
afﬁnity is low, the protein will bind if the concentration
is high (6). Since we did not observe a stress-dependent
modulation of p53 binding afﬁnity to speciﬁc RE, this
suggests that regulation of concentration might be a
more important factor than regulation of afﬁnity for
controlling p53 binding. Interestingly, we observed a
global regulation of p53 binding activity to REs on
naked DNA. Indeed, p53 binding to all REs was virtually
abrogated 12h following UVB exposure, even if p53 levels
remained high. Interestingly, a regulatory mechanism of
this kind might be useful to stop the p53 response to stress.
Nevertheless, while we observed a global decrease in p53
binding activity, we found that high levels of p53 bound to
REs were maintained in cells. Thus, despite the loss of
binding activity of late accumulated p53, REs remained
occupied by p53 induced at early response stages. This
indicates that the global inhibition of p53 binding only
circumvents p53 interaction with new REs, which might
be a mechanism to prevent the regulation of novel p53
effector genes.
Of note, our results revealed that chromatin is needed
for the modulation of p53’s binding to REs and the
Figure 4. p53 binding to the –2242bp RE is affected by HATi Garcinol. (A) Comparison of p53 binding activities on p21 following UVB irradiation.
p53 binding to the –1354, –2242 and –11708bp REs was measured by DLF in wt ﬁbroblasts exposed to 500 and 2000J/m
2 UVB. (B) Effect of
Garcinol on p53 protein levels in wt ﬁbroblasts exposed to UVB. p53 levels were measured by western blot. (C) Effect of Garcinol on p53 binding
in vitro on naked DNA following UVB irradiation. p53 binding to the –2242bp RE was measured by MAPD. (D) Effect of Garcinol on p53 binding
in cells on chromatin following UVB irradiation. p53 binding to the –2242bp RE was measured in wt ﬁbroblasts using DLF. The gel obtained using
an automated sequencer is presented, negative footprints are indicated by a bar. (E) Quantiﬁcation of negative footprint intensity measured by DLF
at the –2242bp RE. (F) Effect of Garcinol on histone H3 and histone H4 acetylation following UVB irradiation. Levels of histone H3, acetylated
histone H3 (H3Ac), and acetylated histone H4 (H4Ac) were measured by ChIP at the –2242 and –3969bp REs. Results are expressed as ratios of
acetylated histone on histone H3.
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illustrated by the absence of p53 binding to the  11708bp
RE following Nutlin-3 or to the  3969bp RE following
UVB and Nutlin-3 treatments in cells. Regarding the
 3969bp RE, the absence of binding in cells clearly indi-
cates that accessibility to this RE seems to be blocked in a
chromatinized context. It is noteworthy that stress-speciﬁc
p53 binding to the  11708bp RE was only revealed by
DLF and not by ChIP. We ruled out any sensitivity issue
of DLF and attributed this discrepancy to the ability of
p53 to interact with other DNA-binding proteins such as
SP1 and WT1 (39,40). Interestingly, a potential SP1 RE
(50-ggGGGCTGTGTaggt-3) is located close to the
 11708bp RE at  12007bp. Thus, if p53 locates only
at the SP1 RE, ChIP might not be able to differentiate
between binding to the  11708bp p53 RE and binding to
the  12007bp SP1 RE, since DNA fragments encompass-
ing both sites could have been immunoprecipitated. This
might explain the conﬂicting ChIP and DLF data and
shows the limitations of each technique and the advantage
of combining both approaches.
One intriguing question is the role of the multiple REs
present in the p21 promoter. We and others proposed that
the  1354 and  2242bp REs might be involved in the
regulation of p21 variant transcription (11,41). The prox-
imity of the  11709bp RE to the p21 gene also suggests
that it might act as a distal regulator through DNA
looping (11). However, Huarte et al. (42) recently
showed that this RE is involved in the regulation of an
intergenic non-coding RNA that favors apoptosis.
Interestingly, both functions for the  11708bp RE
might not be mutually exclusive and we think that a
co-dependent regulation of both loci could provide a
mechanism to select between cell-cycle arrest and apop-
tosis outcomes.
Finally, the involvement of chromatin remodeling in the
modulation of p53 binding to REs was strongly reinforced
by the observation that the inhibition of histone acetyl-
ation by HATi Garcinol correlates with a decrease of p53
binding to REs in response to stress. Since histone modi-
ﬁcations and chromatin remodeling do occur in a
stress-speciﬁc manner (43), we propose that the formation
of stress-speciﬁc p53 binding patterns could be directed by
the remodeling of chromatin (e.g. histone acetylation).
For example, the HAT p300 [which is recruited by p53
(44,45)], might only be active at certain promoters and
thus increase histone acetylation levels to maintain p53
interaction only at speciﬁc REs. We thus propose a
model in which chromatin acts as a ﬁlter to allow p53
binding to speciﬁc REs, over a model in which p53
binding patterns are caused by the modulation of p530s
afﬁnity to speciﬁc REs (Figure 5). Interestingly, the
deregulation of histone modiﬁcation and chromatin
remodeling does occur during the carcinogenesis process
(46,47). In the perspective provided by our results, this
indicates that cancerous cells are capable of disrupting
p53 binding patterns and in consequence p53’s response
to stress. This mechanism may disrupt the p53 pathway in
p53
+/+ cancerous cells and explain why p53 binding
patterns differ between cancer cells and primary cells
(9–11).
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
Figure 5. Models for selective p53 binding. In the model presented in (A), the formation of p53 binding patterns is driven by the binding afﬁnity of
p53 for RE sequences. It is proposed that p53 binding afﬁnity to REs is modulated by stress-speciﬁc posttranslational modiﬁcations that favor
binding to certain REs (red). In this model, p53 binding patterns should be observed on naked DNA. However, in our experimental setting, p53
binding patterns were virtually identical on naked DNA following the different treatments tested. We thus propose another model (B) where the
afﬁnity of p53 for speciﬁc RE sequences is not modulated differently following stresses, rather, the selectivity of p53 binding is dependent on the
remodeling of chromatin (e.g. histone acetylation) at certain REs (red).
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